| 基本信息 |
|
|---|
| 期刊名字 | NEOPLASIA
NEOPLASIA |
| 期刊ISSN | 1522-8002 |
| 2011-2012最新影响因子 | 5.946 |
| 期刊官方网站 | http://www.neoplasia.com/ |
| 期刊投稿网址 | https://www.editorialmanager.com/NEO |
| 通讯方式 | NEOPLASIA PRESS, 1150 W MEDICAL CENTER DR, MSRB III, RM 9303, ANN ARBOR, USA, MI, 48109-0648 |
| 涉及的研究方向 | 医学-肿瘤学 |
| 出版国家 | UNITED STATES |
| 出版周期 | Monthly |
| 出版年份 | 1999 |
| 中科院SCI期刊分区 | 0 区 |
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1522-8002%5BISSN%5D |
| 平均审稿速度（网友分享经验） | 平均 个月的审稿周期 |
| 平均录用比例（网友分享经验） | 约15%% |
| 该杂志上中国学者近期发表的论文 |
|---|
| 中国学者近期发表的论文 |
|---|
| 1. | Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma.
Author: Wu X, Tao Y, Hou J, Meng X, Shi J.
Journal: Neoplasia. 2012 Dec;14(12):1178-89. | | 2. | A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
Author: Qiu X, Guo G, Chen K, Kashiwada M, Druker BJ, Rothman PB, Chen JL.
Journal: Neoplasia. 2012 Jun;14(6):547-58. | | 3. | The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Author: Yang Y, Jiang H, Gao H, Kong J, Zhang P, Hu S, Shi B, Zhang P, Yao M, Li Z.
Journal: Neoplasia. 2012 Jun;14(6):509-18. | | 4. | Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.
Author: Luo Y, Liu L, Rogers D, Su W, Odaka Y, Zhou H, Chen W, Shen T, Alexander JS, Huang S.
Journal: Neoplasia. 2012 Mar;14(3):228-37. |
|
| 同领域相关期刊 |
|---|
|
| 期刊近年影响因子趋势图 |
|---|
  |
